midi health compounded semaglutide for Weight Loss FDA alerts health care providers,

Semaglutide does not cross the blood-brain barrier, yet it directly targets the brainstem, septal nucleus, and hypothalamus

This article explores the pharmacology of both agents, potential interactions, who might be considered for concurrent use, and the safety considerations and monitoring requirements that any clinician or patient should understand before combining these treatments

GLP-1 secretion is regulated by IL-6 signalling: A randomised, placebo-controlled study

Shes so knowledgeable and explains everything in detail. Felt welcomed the second I walked in

Myth: GLP-1 Medications are Unsafe for Long-Term Use The safety profile of GLP-1 medications is robust, backed by extensive clinical trials and ongoing real-world studies